Heramed (ASX: HMD) — Perfil da empresa, notícias e dados financeiros
Heramed is a medical technology company specializing in digital health solutions and remote monitoring tools for maternity and women's healthcare.
Heramed
Heramed is a medical technology company specializing in digital health solutions and remote monitoring tools for maternity and women's healthcare. The company develops connected medical devices and software platforms designed to improve remote fetal monitoring, telehealth engagement, and clinical workflows. Its core offering combines smart ultrasound fetal heart rate monitors with cloud-based clinician dashboards and patient-facing artificial intelligence software. By enabling remote data collection and automated clinical documentation, the company supports healthcare providers in offering continuous prenatal care, risk identification, and personalized care pathways across fertility, pregnancy, postpartum, and general women's health stages.
Resumo
Operações
Produtos e/ou serviços de Heramed
- Remote Fetal Doppler: Medical-grade connected ultrasound technology for continuous home and clinical monitoring of fetal heart rates and maternal vital signs, facilitating real-time data transmission and early detection of potential obstetric complications during pregnancy.
- AI Clinician Dashboard: Centralized enterprise software platform aggregating maternal vital metrics, encounter records, and risk alerts, featuring embedded ambient AI speech processing to automatically capture telehealth interactions and generate structured clinical notes.
- AI Patient Engagement: Mobile health application providing patients with an interactive virtual assistant delivering tailored medical education, medication reminders, stage-based symptom triage, and proactive engagement to maintain continuous communication between clinical visits.
- Integrated Telehealth Platform: Digital care infrastructure facilitating synchronous and asynchronous virtual consultations, care plan management, and remote medical encounters between women and multi-disciplinary clinical teams throughout prenatal and postpartum periods.
- Longitudinal Women's Care: Comprehensive digital health solution extending remote patient monitoring and continuous clinical management across various life stages, including fertility tracking, high-risk maternity care, postpartum depression screening, and chronic condition management.
- Care Pathway Designer: Enterprise software tool enabling healthcare systems and clinical providers to design, customize, and deploy standardized digital care protocols, automated risk stratification models, and remote patient monitoring workflows.
equipe executiva do Heramed
- Anoushka GungadinMD, CEO & Director
- Cameron Peter JonesCFO & Joint Company Secretary
- Vivek KrishnanChief Technology Officer
- Henry JordanHead of Investor Relations
- Mandy KhairaChief Clinical Transformation Officer & Chief Medical Officer
- Nicole ZappalaHead of Customer Success
- Jeff GaribaldiChief Growth Officer
- Nova Anne TaylorJoint Company Secretary
Últimas notícias sobre a Heramed
Comunicados recentes
O que a Heramed (HMD) comunicou ao mercado, do mais recente para o mais antigo.
- Application for quotation of securities - HMD
Principais indicadores financeiros
Resultados divulgados pela Heramed, em AUD.
- Cap. de mercado
- 42,9 mi
- Receita (TTM)
- 330,4 mil
- P/L
- —
- LPA (diluído, TTM)
- 0.0
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 195,8 mil | -2,7 mi | -2,8 mi | |
| 225,5 mil | -5,6 mi | -3,4 mi | |
| 413,2 mil | -4,5 mi | -4,5 mi | |
| 215,8 mil | -3,2 mi | -4,9 mi |